Vitrectomy with internal limiting membrane peeling for tractional and nontractional diabetic macular EDEMA: Long-term Results of a Comparative Study

Retina

Volumn 35, Issue 5, 2015, Pages 921-928

  Bonnin, Sophie ^a   Sandali, Otman ^a   Bonnel, Sébastien ^a   Monin, Claire ^a   El Sanharawi, Mohamed ^a,b  

^a CENTRE HOSPITALIER NATIONAL D OPHTALMOLOGIE DES QUINZE VINGTS   (France)

^b INSERM   (France)

Author keywords

diabetes; macular edema; vitrectomy

Indexed keywords

BRILLIANT BLUE; CORTICOSTEROID; INDOCYANINE GREEN; SILICONE OIL; TRIAMCINOLONE; VASCULOTROPIN ANTIBODY;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BEST CORRECTED VISUAL ACUITY; CATARACT; CATARACT EXTRACTION; CENTRAL MACULAR THICKNESS; CLINICAL FEATURE; COMPARATIVE STUDY; CORTICOSTEROID THERAPY; CRYOTHERAPY; DIABETIC MACULAR EDEMA; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; ENDOLASER; FEMALE; FOLLOW UP; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTERNAL LIMITING MEMBRANE PEELING; INTRAOCULAR HEMORRHAGE; INTRAOCULAR PRESSURE; INTRAVITREAL HEMORRHAGE; IRIS RUBEOSIS; LASER COAGULATION; MACULAR THICKNESS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PROLIFERATIVE DIABETIC RETINOPATHY; RETINA DETACHMENT; RETINA SURGERY; RETINA TEAR; SCLERAL BUCKLE; SYSTOLIC BLOOD PRESSURE; VISUAL ACUITY; VITRECTOMY; BASEMENT MEMBRANE; COMPLICATION; DIABETIC RETINOPATHY; EPIRETINAL MEMBRANE; MACULAR EDEMA; MIDDLE AGED; OPTICAL COHERENCE TOMOGRAPHY; PATHOPHYSIOLOGY; PHYSIOLOGY; POSTOPERATIVE COMPLICATION; RETROSPECTIVE STUDY;

ADULT; AGED; BASEMENT MEMBRANE; CRYOTHERAPY; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; EPIRETINAL MEMBRANE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LASER COAGULATION; MACULAR EDEMA; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY; VITRECTOMY;

EID: 84928988593     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0000000000000433     Document Type: Article

References (25)

1. Brown DM, Nguyen QD, Marcus DM, et al. Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE. Ophthalmology 2013;120:2013-2022.
2. Lang GE, Berta A, Eldem BM, et al. Two-year safety and efficacy of ranibizumab 0.5 mg in diabetic macular Edema: interim analysis of the RESTORE extension study. Ophthalmology 2013;120:2004-2012.
3. Mitchell P, Bandello F, Schmidt-Erfurth U, et al. The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology 2011;118:615-625.
4. Bressler SB, Qin H, Beck RW, et al. Factors associated with changes in visual acuity and central subfield thickness at 1 year after treatment for diabetic macular edema with ranibizumab. Arch Ophthalmol 2012;130:1153-1161.
5. Do DV, Nguyen QD, Khwaja AA, et al. Ranibizumab for edema of the macula in diabetes study: 3-year outcomes and the need for prolonged frequent treatment. JAMA Ophthalmol 2013;131:139-145.
6. Smiddy WE. Economic Considerations of macular edema therapies. Ophthalmology 2011;118:1827-1833.
7. Laidlaw DA. Vitrectomy for diabetic macular oedema. Eye (Lond) 2008;22:1337-1341.
8. Massin P, Duguid G, Erginay A, et al. Optical coherence tomography for evaluating diabetic macular edema before and after vitrectomy. Am J Ophthalmol 2003;135:169-177.
9. Kumagai K, Furukawa M, Ogino N, et al. Long-term follow-up of vitrectomy for diffuse nontractional diabetic macular edema. Retina 2009;29:464-472.
10. Wolf-Schnurrbusch UE, Ceklic L, Brinkmann CK, et al. Macular thickness measurements in healthy eyes using six different optical coherence tomography instruments. Invest Ophthalmol Vis Sci 2009;50:3432-3437.
11. Lewis H, Abrams G, Blumenkranz M, Campo R. Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction. Ophthalmology 1992;99:753-759.
12. Elman MJ, Aiello LP, Beck RW, et al. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology 2010;117:1064-1077.e35.
13. Yanyali A, Horozoglu F, Celik E, Nohutcu AF. Long-term outcomes of pars plana vitrectomy with internal limiting membrane removal in diabetic macular edema. Retina 2007;27:557-566.
14. Yamamoto T, Takeuchi S, Sato Y, Yamashita H. Long-term follow-up results of pars plana vitrectomy for diabetic macular edema. Jpn J Ophthalmol 2007;51:285-291.
15. Patel JI, Hykin PG, Schadt M, et al. Pars plana vitrectomy with and without peeling of the inner limiting membrane for diabetic macular edema. Retina 2006;26:5-13.
16. Kumar A, Sinha S, Azad R, et al. Comparative evaluation of vitrectomy and dye-enhanced ILM peel with grid laser in diffuse diabetic macular edema. Graefes Arch Clin Exp Ophthalmol 2007;245:360-368.
17. Figueroa MS, Contreras I, Noval S. Surgical and anatomical outcomes of pars plana vitrectomy for diffuse nontractional diabetic macular edema. Retina 2008;28:420-426.
18. Hoerauf H, Brüggemann A, Muecke M, et al. Pars plana vitrectomy for diabetic macular edema. Internal limiting membrane delamination vs posterior hyaloid removal. A prospective randomized trial. Graefes Arch Clin Exp Ophthalmol 2011; 249:997-1008.
19. Stefánsson E. Ocular oxygenation and the treatment of diabetic retinopathy. Surv Ophthalmol 2006;51:364-380.
20. Stefánsson E. Physiology of vitreous surgery. Graefes Arch Clin Exp Ophthalmol 2009;247:147-163.
21. Funatsu H, Yamashita H, Ikeda T, et al. Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with diabetic macular edema and other retinal disorders. Am J Ophthalmol 2002;133:537-543.
22. Stefaniotou M, Aspiotis M, Kalogeropoulos C, et al. Vitrectomy results for diffuse diabetic macular edema with and without inner limiting membrane removal. Eur J Ophthalmol 2004;14:137-143.
23. Bahadir M, Ertan A, Merto-glu O. Visual acuity comparison of vitrectomy with and without internal limiting membrane removal in the treatment of diabetic macular edema. Int Ophthalmol 2006;26:3-8.
24. Saravia M. Persistent diffuse diabetic macular edema. The role of the internal limiting membrane as a selective membrane: the oncotic theory. Med Hypotheses 2011;76:858-860.
25. Tamura K, Yokoyama T, Ebihara N, Murakami A. Histopathologic analysis of the internal limiting membrane surgically peeled from eyes with diffuse diabetic macular edema. Jpn J Ophthalmol 2012;56:280-287.